Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator. (Q51564741)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2004
edit
Language Label Description Also known as
English
Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator.
scientific article published in December 2004

    Statements

    Development of cardiovascular drugs: the U.S. regulatory milieu from the perspective of a participating nonregulator. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit